Headquartered in Switzerland – a biotech-hub of Europe – Idorsia is a high-potential biopharmaceutical company, specialized in the discovery, development and commercialization of innovative small molecules, with the aim of transforming the horizon of therapeutic options.
The purpose of Idorsia is to discover, develop, and commercialize innovative medicines to help more patients.
We have more ideas, we see more opportunities, and we want to transform the horizon of therapeutic options.
In order to achieve this, we will develop Idorsia into a leading biopharmaceutical company, with a strong scientific core.
Our success depends on our people. Our talented and diverse team is passionate about science, and we are committed to working collaboratively to bring new medicines to patients.
Idorsia has a strong and visionary leadership team with the power and drive to create more remarkable innovations and more new medicines.
Idorsia considers sophisticated partnerships to strategically access technologies or products, and to maximize the value of our discovery engine and clinical pipeline.